Tinzaparin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 50.0%
Deep Vein Thrombosis 16.7%
Thrombosis Prophylaxis 16.7%
Acute Coronary Syndrome 5.6%
Pulmonary Arterial Hypertension 5.6%
Systemic Lupus Erythematosus 5.6%
Pneumonia Aspiration 20.0%
Intestinal Ischaemia 10.0%
Spinal Compression Fracture 10.0%
Thrombocytopenia 10.0%
Cardiac Failure 5.0%
Deep Vein Thrombosis 5.0%
Legionella Infection 5.0%
Oxygen Saturation Decreased 5.0%
Pulmonary Embolism 5.0%
Sepsis 5.0%
Septic Shock 5.0%
Sinus Tachycardia 5.0%
Vena Cava Thrombosis 5.0%
White Blood Cell Count Decreased 5.0%
Secondary
Drug Use For Unknown Indication 53.3%
Anticoagulant Therapy 13.3%
Diffuse Large B-cell Lymphoma 7.5%
Product Used For Unknown Indication 6.7%
Deep Vein Thrombosis 5.5%
Antiplatelet Therapy 2.4%
Multiple Myeloma 2.0%
Colon Cancer 1.6%
Small Cell Lung Cancer Extensive Stage 1.6%
Thrombosis Prophylaxis 1.6%
Atrial Fibrillation 1.2%
Left Ventricular Failure 1.2%
Small Cell Lung Cancer Stage Unspecified 0.8%
Crohn's Disease 0.4%
Lower Respiratory Tract Infection 0.4%
Pneumonia Aspiration 0.4%
Toxic Epidermal Necrolysis 0.4%
Pneumonia Aspiration 14.5%
Toxic Epidermal Necrolysis 14.5%
Intestinal Ischaemia 9.7%
Motor Dysfunction 9.7%
Cardiac Failure 4.8%
Legionella Infection 4.8%
Neurolysis 4.8%
Paraesthesia 4.8%
Septic Shock 4.8%
Thrombosis 4.8%
Cerebrovascular Accident 3.2%
Deep Vein Thrombosis 3.2%
Pulmonary Embolism 3.2%
Squamous Cell Carcinoma Of Skin 3.2%
Cerebral Haemorrhage 1.6%
Haematoma 1.6%
Haemoglobin Decreased 1.6%
Haemoptysis 1.6%
Large Intestinal Obstruction 1.6%
Optic Disc Haemorrhage 1.6%
Concomitant
Drug Use For Unknown Indication 25.4%
Product Used For Unknown Indication 23.9%
Pain 7.3%
Prophylaxis Of Nausea And Vomiting 6.5%
Prophylaxis 5.8%
Hypertension 4.4%
Constipation 3.8%
Breast Cancer 3.1%
Multiple Myeloma 2.5%
Thrombosis Prophylaxis 2.2%
Deep Vein Thrombosis 2.0%
Nausea 1.9%
Prostate Cancer Metastatic 1.9%
Pulmonary Embolism 1.8%
Atrial Fibrillation 1.6%
Anticoagulant Therapy 1.4%
Infection 1.2%
Ovarian Cancer 1.1%
Plasma Cell Myeloma 1.1%
Non-small Cell Lung Cancer 1.0%
Pulmonary Embolism 16.0%
Febrile Neutropenia 9.2%
Pain 5.9%
Pneumonia 5.9%
Death 5.0%
Spinal Fracture 5.0%
Thrombocytopenia 5.0%
Vomiting 5.0%
Neutropenia 4.2%
Neutropenic Sepsis 4.2%
White Blood Cell Count Decreased 4.2%
Duodenal Ulcer 3.4%
Intestinal Anastomosis Complication 3.4%
Malignant Neoplasm Progression 3.4%
Oesophageal Candidiasis 3.4%
Off Label Use 3.4%
Pancytopenia 3.4%
Polyarthritis 3.4%
Spinal Cord Compression 3.4%
Tetany 3.4%
Interacting
Drug Use For Unknown Indication 58.3%
Deep Vein Thrombosis 16.7%
Immunodeficiency 8.3%
Pain 8.3%
Pulmonary Embolism 8.3%
Drug Interaction 100.0%